DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and ...

Single-sided deafness (SSD) is characterised by a severe to profound sensorineural hearing loss in one ear, with normal or near‐normal hearing in the contralateral ear. Traditionally, management ...

The FDA has approved SYNCHRONY and SYNCHRONY 2 (MED-EL) cochlear implant systems for single-sided deafness and asymmetric hearing loss. The Food and Drug Administration (FDA) has approved SYNCHRONY ...

LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...

Existing treatment options, which include hearing aids or bone conduction devices, often fail to address these issues because they generally only serve to reroute sound signals from one ear to the ...

Durham, N.C.-based Med-El North America received a thumbs up from the FDA for use of its cochlear implant systems in people with single-sided deafness (SSD) and asymmetrical hearing loss (AHL). The ...

Single-sided deafness (SSD) is a hearing impairment that affects at least one in every 1,000 babies born. These infants have severe-to-profound hearing loss in one ear with normal or near-normal ...

The committee was formed to assess the Hearing in Noise Test (HINT) and alternatives tests with similar characteristics for adults and children with cochlear implants. The report will identify the ...

MINNEAPOLIS — It is one of life's time-honored truths. Kids lose stuff. Usually it's money, a shoe, a favorite sweatshirt or a house key. Losing them is inconvenient, or emotionally upsetting, but ...

Single-sided deafness (SSD) is a hearing impairment that affects at least one in every 1,000 babies born. These infants have severe-to-profound hearing loss in one ear with normal or near-normal ...